Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment
Clinical trial NCT07078305 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07078305
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-01
- Primary completion
- 2026-08-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.